Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Tesamorelin
View:
Post by palinc2000 on Oct 11, 2023 7:16pm

Tesamorelin

Is our most important asset at the moment and might become in the not too distant future a blocbuster!!!!
Fantastic posts by Scarlett and we should all be thankful to have  Scarlett supply this MB with many great finds! 

Refreshing compared to all the lament by some

Comment by scarlet1967 on Oct 11, 2023 7:32pm
Thank you!
Comment by Joemare on Oct 12, 2023 10:07am
They need to plant seeds for a combo trial.  Regeron,, Novo, etc...plant seeds. Get Grinspoon out there. THey need to get their medical liason dudes working harder. 
Comment by Trogarzon on Oct 12, 2023 10:27am
Shure do.  But these markets react like in 2000.  Nohing works for the stock at the moment.  The need to surprise with something material.  A partner, a new product, a new CEO.... a buyer.
Comment by Trogarzon on Oct 12, 2023 11:50am
Anyway, we learned lately that Nash may still have appeal in light of Akero's failings and F8 submission.  We also learned that Th1902 is back on track.  They were considered backupted 2 months ago because of the ongoing concern BS and Marathon's shitshow.
Comment by Wino115 on Oct 12, 2023 1:02pm
Akero was unfortunate for the overall NASH market, but does mean solutions beyond Madrigal may still have a market. Althought, they may get it back on track. Back in those days of all the expert talking heads, they all agreed there will be multiple therapies because the disease has multiple pathways.  Some will work on certain types better than others, and combos may be tried.  That' ...more  
Comment by scarlet1967 on Oct 12, 2023 9:15pm
A couple of years ago the company was invited to a panel discussion with some other companies including MDGL and I remember the CEO invited other companies to join THTX in a combo trial, since then they have altered their NASH trial from phase 3 to now phase 2B/3 in order to reduce the costs and risks trying to make it more feasible for potential partners but so far no bites. The issue is even the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities